Overview

Clinical Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension

Status:
Completed

Trial end date:
2016-09-28

Target enrollment:

Participant gender:

Summary

Study to evaluate if macitentan is efficient, safe and tolerable enough to be used for treatment of inoperable chronic thromboembolic pulmonary hypertension (CTEPH).

Phase:

Phase 2

Details

Lead Sponsor:

Actelion

Treatments:

Macitentan